Charles River Laboratories Announces Second-Quarter 2022 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/12/2026
- Nasdaq falls ahead of earnings, economic data while oil rallies
- Oil prices rise on Saudi Arabia attacks, overshadowing Trump's diesel deal
- Will surging equity supply derail the U.S. bull market? Goldman Sachs weighs in
- Broadcom CEO says many AI investors are gamblers
- "Not buying Chipotle": Starbucks squashes blockbuster acquisition speculation
- One dead in new attack on Saudi airport, a day after Houthi strike kills 13
- Bausch + Lomb names Appio interim CEO as Saunders departs
- Cerebras Systems hits new 52-week low on unlock concerns
- Getty Images to go private via prepackaged Chapter 11 restructuring
- Kroger (KR) To Cut Corporate Workforce By About 3,000 Over 3 Years - Bloomberg
Charles River Laboratories (CRL) Tops Q2 EPS by 2c; Lowers Outlook
August 3, 2022 7:03 AM EDTCharles River Laboratories (NYSE: CRL) reported Q2 EPS of $2.77, $0.02 better than the analyst estimate of $2.75. Revenue for the quarter came in at $973.1 million versus the consensus estimate of $997.96 million.
GUIDANCE:
Charles River Laboratories sees FY2022 EPS of $10.70-$10.95, versus the... More



